NTRR Formulates Plan to Dramatically Reduce Global Alcohol Addiction


NTRR Formulates Plan to Dramatically Reduce Global Alcohol Addiction

TAMPA, Fla.--(BUSINESS WIRE)-- As the United States and other nations, struggle with high rates of alcohol abuse and addiction, Neutra Corp. (OTCBB: NTRR) is developing a business plan to help eliminate the social health costs that alcoholism wreaks around the globe.

According to figures from the Substance Abuse and Mental Health Services Administration's (SAMHSA) 2011 National Survey on Drug Use and Health, there are an estimated 133.4 million current drinkers of alcohol in the U.S. Nearly a quarter of the nation's population 12 or older participated in binge drinking at least once in the 30 days prior to the survey in 2011, a total of 58.3 million people.

15.9 million Americans are estimated to engage in "heavy drinking," defined as taking five or more drinks on the same occasion on five or more days in the past month. Many are unable to stop.

NTRR is working to change that. The company is moving forward with plans to deliver innovative new medical addiction treatments to users for whom traditional rehabilitation and treatment aren't enough.

"Today, nearly everyone understands that alcohol addiction is not simply a poor lifestyle choice, but a powerful disease that can swallow people whole," said NTRR CEO Michael-Shane Henderson. "It's time we began treating this disease with cutting-edge medical research and technology rather than with prayer and willpower alone."

NTRR aims to offer a holistic approach to eliminate addiction cravings in the brain. Earlier this week, the company announced that it's begun shortlisting promising business targets in the medical technology space capable of helping to deliver the effective new treatments NTRR is looking for.

For more information on NTRR's efforts to market effective remedies for common afflictions, please visit www.neutracorp.com/investors.html.

Follow NTRR on Twitter at www.twitter.com/neutracorp.

About Neutra Corp.

Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of nutritional supplements, nutrient boosters, herbal remedies and other natural wellness solutions. The company is currently working to produce a full range of products to address every component of a healthy lifestyle, including muscle building, weight loss and general wellness through a daily nutrition regimen. For investing information and performance data, please visit www.neutracorp.com/investors.html.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Neutra Corp.
Michael-Shane Henderson, 713-821-1486
President and CEO

KEYWORDS: United States North America Florida


The article NTRR Formulates Plan to Dramatically Reduce Global Alcohol Addiction originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.